DIALF yields 48.78% · JNJ yields 2.14%● Live data
📍 DIALF pulled ahead of the other in Year 1
Combined, DIALF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DIALF + JNJ for your $10,000?
Dialight plc, together with its subsidiaries, primarily develops, manufactures, and supplies LED lighting solutions for use in hazardous and industrial applications in North America, EMEA, and internationally. The company operates in two segments, Lighting, and Signals & Components. It offers high and low bays, and high outputs; conveyor, street, area, and flood lights; LED linear fixtures, such as low profile/top conduit linear, stainless steel linear, glass reinforced polyester linear, battery backup linear, and end-to-end linear; and wall packs/bulkheads products. The company also provides lighting products for control systems and obstruction solutions. In addition, it offers signals and components, such as panel mount and circuit board indicators; and traffic, vehicle, and rail products. The company serves mining, heavy industry, oil and gas, petrochemical, power generation, pulp and paper, food and beverage, and traffic and signal sectors. Dialight plc was founded in 1938 and is headquartered in London, the United Kingdom.
Full DIALF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.